Device for exerting physiotherapeutic action

IPC classes for russian patent Device for exerting physiotherapeutic action (RU 2246331):

A61N5/06 - using light (A61N0005010000 takes precedence);;

A61H33 - Bathing devices for special therapeutic or hygienic purposes (A61H0035000000 takes precedence;for subaquatic intestinal cleaning A61M0009000000; electric or magnetic baths, applying ionised fluids A61N0001440000)

Another patents in same IPC classes:

Method for acting upon aids virus / 2245178

Method involves exposing cells containing virus to radiation. Pulsating monochromatic light with pulses succession frequency being equal to 9.4 Hz is applied with wavelength group of 516.7, 517.2, 518.2 nm and then with 636.2 nm of total power not less than 400W. Power ratios in wavelength group is first equal to 1:0 then 1:1,1:3, 3:1, 0:1. Exposure time is equal to at the level of 20 min.

Device for anestesia / 2245176

The device has a quantum-mechanical oscillator located in a casing, magnet, vessel for medicinal agent and a hollow cylinder. The magnet is installed between the oscillator and the vessel. Positioned in the vessel is a hollow cylinder having through holes on its surface.

Method for applying electrochemical destruction, surgical removal and photodynamic prophylaxis for treating the cases of intraocular neoplasms in perfluororganic medium / 2244533

Method involves filling vitreous cavity with perfluororganic compound. Two electrodes manufactured from platinum group metal are intravitreally, transretinally introduced into intraocular neoplasm. Electrochemical destruction is carried out with current intensity of 10-100 mA during 1-10 min in changing electrodes polarity and their position in the intraocular neoplasm space, and the electrodes are removed. 0.1-1% aqueous solution of khlorin as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, is intravenously introduced at a dose of 0.8-1.1 mg/kg. Visual control of intraocular neoplasm cells fluorescence is carried out by applying fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, intravitreous, transretinal laser radiation of 661-666 nm large wavelength is applied at a dose of 30-120 J/cm² in perfluororganic compound medium. The transformed retina and tumor destruction products are intravitreally removed with perfluororganic compound volume being compensated with its additional introduction. Boundary-making endolasercoagulation of retinotomy area is carried out. The perfluororganic compound is substituted with silicon oil. The operation is ended in placing sutures over sclerotmy areas and over conjunctiva. Perfluormetylcyclohexylperidin, perfluortributylamine or perfluorpolyester or like are used as the perfluororganic compound for filling vitreous cavity. Platinum, iridium or rhodium are used as the platinum group metals.

Surgical removal and photodynamic method for treating subretinal neovascular membranes / 2244532

Method involves building tunnel to posterior eyeball pole in inferoexterior and superexterior quadrants. The tunnel is used for implanting flexible polymer magnetolaser implant to the place, the subretinal neovascular membrane is localized. The implant has a permanent magnet shaped as a cut ring and is provided with drug delivery system and a short focus scattering lens of laser radiator connected to light guide. The permanent implant magnet is axially magnetized and produces permanent magnetic field of 5-7 mTesla units intensity. It is arranged with its north pole turned towards sclera at the place of the subretinal neovascular membrane projection with extrascleral arrangement of laser radiator lens membrane being provided in the subretinal neovascular membrane projection area. The other implant end is sutured to sclera 5-6 mm far from the limb via holes made in advance. The implant is covered with conjunctiva and retention sutures are placed thereon. Light guide and drug supply system lead is attached to temple with any known method applied. Drugs are supplied via the implant drug supply system in retrobulbary way in any order. Triombrast is given in the amount of 0,4-0,6 ml and dexamethasone or dexone in the amount of 0,4-0,6 ml during 3-4 days every 12 h. 0.1-1% aqueous solution of khlorin is intravenously introduced at the third-fourth day after setting the implant as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, at a bolus dose of 0.8-1.1 mg/kg. Visual control of subretinal neovascular membrane cells fluorescence is carried out by applying fluorescent diagnosis methods. After saturating the subretinal neovascular membrane with the photosensitizer to maximum saturation level, intravitreous, transretinal laser radiation of 661-666 nm large wavelength is applied at general dose of 30-120 J/cm². The flexible polymer magnetolaser implant is removed and sutures are placed on conjunctiva. Permanent magnet of the flexible polymer magnetolaser implant is manufactured from samarium-cobalt, samarium-iron-nitrogen or neodymium-iron-boron system material. The photosensitizer is repeatedly intravenously introduced at the same dose in 2-3 days after the first laser radiation treatment. Visual intraocular neoplasm cells fluorescence control is carried out using fluorescent diagnosis techniques. Maximum level of saturation with the photosensitizer being achieved in the subretinal neovascular membrane via laser light guide and implant lens, repeated laser irradiation of the subretinal neovascular membrane is carried out with radiation dose of 30-60 J/cm².

Electrochemical destruction, surgical removal and photodynamic method for treating and preventing from intraocular neoplasms / 2244531

Method involves intravitreously introducing two electrodes into intraocular neoplasm after carrying out vitrectomy and retinotomy to expose the intraocular neoplasm. The electrodes are manufactured from platinum group metal. Electrochemical destruction is carried out with current intensity of 100 mA during 1-10 min or 10 mA during 10 min in changing electrodes polarity and their position in the intraocular neoplasm space, and the electrodes are removed. 0.1-1% aqueous solution of khlorin as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, is intravenously introduced at a dose of 0.8-1.1 mg/kg. Visual control of intraocular neoplasm cells fluorescence is carried out by applying fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, intravitreous laser radiation is carried out in parallel light beam of wavelength equal to 661-666 nm is applied at a dose of 30-120 J/cm².The transformed retina and tumor destruction products are intravitreally removed. Boundary-making endolasercoagulation of retinotomy area is carried out after having smoothed and compressed retina with perfluororganic compound. The operation is finished with placing sutures on sclerotomy and conjunctiva. Platinum, iridium or rhodium are used as the platinum group metals. Another embodiment of the invention involves adjusting position and size of the intraocular neoplasm in trans-scleral diaphanoscopic way. Rectangular scleral pocket is built above the intraocular neoplasm to 2/3 of sclera thickness with its base turned away from limb. Several electrodes are introduced into intraocular neoplasm structure via the built bed. The electrodes are manufactured from platinum group metal. Electrochemical destruction is carried out with the same current intensity in changing electrodes polarity and their position in the intraocular neoplasm space, and the electrodes are removed. Superficial scleral flat is returned to its place and fixed with interrupted sutures. 0.1-1% aqueous solution of khlorin as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, is intravenously introduced at a dose of 0.8-1.1 mg/kg after having carried out vitrectomy and retinotomy. Visual control of intraocular neoplasm cells fluorescence is carried out by applying fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, intravitreous laser radiation is carried out in parallel light beam of wavelength equal to 661-666 nm is applied at a dose of 30-120 J/cm². The transformed retina and tumor destruction products are intravitreally removed using vitreotome. Boundary-making endolasercoagulation of retinotomy area is carried out after having smoothed and compressed retina with perfluororganic compound. The operation is finished with placing sutures on sclerotomy and conjunctiva. Platinum, iridium or rhodium are used as the platinum group metals. The number of electrodes is equal to 4-8.

Method for treating vascular cutaneous neoplasms / 2243792

The present innovation deals with treating vascular cutaneous neoplasms, such as nevus flammeus and gemangiomas. Light-thermal impact at energy ranged 39-47 J/sq. cm should be performed in two stages, and between them, 2-3 wk after the onset of vascular resistance at the first stage one should perform beta-therapy daily for 2-3 d at single dosage being 20 g. Then, 3 wk later it is necessary to conduct the second stage of light-thermal impact by starting at energy value being 42 J/sq. cm, not less. The method enables to shorten therapy terms due to applying combined method to affect vascular cutaneous neoplasms.

Method for treating the cases of caries with silver nitrate / 2243775

Method involves preparation dental surface, covering it with 30% aqueous solution of silver nitrate and recovery agent for precipitating insoluble silver salts. Silver salts precipitation is carried out by exposing silver nitrate covering tooth surface with halogen radiation of the kind produced by halogen lamp of 12 W or 75 W having spectral bandwidth of 400…500 nm provided with light guide for concentrating luminous flux for 60 s.

Electrochemical destruction and photodynamic surgical method for treating the cases of intraocular neoplasms / 2243755

Method involves applying transscleral diaphanoscopic examination method for adjusting intraocular neoplasm localization and size. Rectangular scleral pocket is built 2/3 times as large as sclera thickness which base is turned from the limb. Several electrodes manufactured from a metal of platinum group are introduced into intraocular neoplasm structure via the built scleral pocket. Next to it, intraocular neoplasm electrochemical destruction is carried out in changing electrodes polarity with current intensity of 100 mA during 1-10 min, and the electrodes are removed. Superficial scleral flap is returned to its place and fixed with interrupted sutures. 0.1-2% aqueous solution of khlorin as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, is intravenously introduced at a dose of 0.8-1.1 mg/kg. Visual control of intraocular neoplasm cells is carried out by applying fluorescence and fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, transpupillary laser radiation of 661-666 nm large wavelength is applied at a dose of 30-120 J/cm². the operation is ended with placing sutures on conjunctiva. Platinum, iridium or rhodium are used as the metals of platinum group. The number of electrodes is equal to 4-8. 0.1-1% khlorin solution, selected from group containing photolon, radachlorine or photoditazine, is additionally repeatedly intravenously introduced in 2-3 days at a dose of 0.8-1.1 mg/kg. Visual control of intraocular neoplasm cells is carried out by applying fluorescence and fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, repeated laser irradiation of the intraocular neoplasm is carried out with radiation dose of 30-45 J/cm².

Photodynamic surgical method for treating the cases of intraocular neoplasms / 2243754

Method involves creating tunnel between sclera and Tenon's capsule in intraocular neoplasm projection. Intraocular neoplasm localization and size is adjusted by applying transscleral diaphanoscopic examination method. 0.1-0.3 ml of photosensitizing gel based on viscoelastic of hyaluronic acid, selected from group containing chealon, viscoate or hyatulon, is transsclerally introduced into intraocular neoplasm structure using special purpose needle in dosed manner. The photosensitizing gel contains khlorin, selected from group containing photolon, radachlorine or photoditazine in the amount of 0.1-1% by mass. Flexible polymer magnetolaser implant is extrasclerally introduced into the built tunnel in intraocular neoplasm projection zone under visual control using guidance beam. The implant has permanent ring-shaped magnet axially magnetized and producing permanent magnetic field of 3-4 mTesla units intensity, in the center of which a short focus scattering lens of laser radiator is fixed. The lens is connected to light guide in soft flexible envelope. The implant is arranged with its north pole turned towards the intraocular neoplasm so that implant laser radiator lens is extrasclerally arranged in intraocular neoplasm projection zone. The implant light guide is sutured to sclera 5-6 mm far from the limb with single interrupted suture. The implant is covered with conjunctiva and relaxation sutures are placed over it. Light guide outlet is attached to temple using any known method. Visual control of intraocular neoplasm cells is carried out by applying fluorescence and fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, transscleral intraocular neoplasm laser radiation treatment is carried out via laser light guide and implant lens using divergent laser radiation at wavelength of 661-666 nm. The treatment course being over, the flexible polymer magnetolaser implant is removed and sutures are placed on conjunctiva. Permanent magnet of the flexible polymer magnetolaser implant is manufactured from samarium-cobalt, neodymium-iron-boron or samarium-iron-nitrogen. 0.1-1% khlorin solution as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, is additionally intravenously introduced in 2-3 days at a dose of 0.8-1.1 mg/kg and repeated laser irradiation of the intraocular neoplasm is carried out with radiation dose of 30-45 J/cm² 15-20 min later during 30-90 s.

Photodynamic surgical method for treating the cases of choroid hemangioma / 2243753

Method involves making incision in conjunctiva and Tenon's capsule of 3-4 mm in size in choroid hemangioma projection to sclera 3-4 mm far from limb. Tunnel is built between sclera and Tenon's capsule to extrasclerally introduce flexible polymer magnetolaser implant through the tunnel to the place, the choroid hemangioma is localized, after performing transscleral diaphanoscopic adjustment of choroid hemangioma localization and size, under visual control using guidance beam. The implant has permanent ring-shaped magnet in the center of which a short focus scattering lens of laser radiator is fixed. The lens is connected to light guide in soft flexible envelope. The permanent implant magnet is axially magnetized and produces permanent magnetic field of 2-3 mTesla units intensity. It is arranged with its north pole turned towards the choroid hemangioma so that extrascleral implant laser radiator disposition. The other end of the implant is sutured to sclera 5-6 mm far from the limb with two interrupted sutures through prefabricated openings. The implant is covered with conjunctiva and relaxation sutures are placed over it. Light guide outlet is attached to temple using any known method. 0.1-1% khlorin solution is injected in intravenous bolus dose of 0.8-1.1 mg/kg as photosensitizer and visual control of choroid hemangioma cells fluorescence and fluorescent diagnosis methods are applied. After saturating choroid hemangioma with the photosensitizer to maximum level, transscleral choroid hemangioma laser radiation treatment is carried out via laser light guide and implant lens using divergent laser radiation at wavelength of 661-666 nm with total radiation dose being equal to 30-120 J/cm². The flexible polymer magnetolaser implant is removed and sutures are placed on conjunctiva. Permanent magnet of the flexible polymer magnetolaser implant is manufactured from samarium-cobalt, samarium-iron-nitrogen or neodymium-iron-boron system material. The photosensitizer is repeatedly intravenously introduced at the same dose in 2-3 days after the first laser radiation treatment. Visual intraocular neoplasm cells fluorescence control is carried out using fluorescent diagnosis techniques. Maximum level of saturation with the photosensitizer being achieved in the intraocular neoplasm, repeated laser irradiation of the choroid hemangioma is carried out with radiation dose of 30-60 J/cm².

Mud tampon / 2245129

The tampon has an envelope filled with mud, head with the recess built in the cavity of the rear section of the envelope, limiter placed on the recess of the tail, socket screwed in the threaded section of the tail and two electrodes. One of them is installed in the cavity of the head, and the other - in the cavity of the tail. The electric wire is positioned in the cavity of the envelope in the longitudinal axis. One end of it is connected to the head electrode, and the other - to one of the terminals of the socket. The wire couples the tail electrode to the second terminal of the socket. The electric cord with a plug connects the socket to the current source. The electrodes are positioned opposite each other. The electric wire is placed in a non-conducting tube.

A method of treating secondary pancreatitis in children at the resort / 2242962

The invention relates to medicine and for the treatment of children suffering from pancreatitis secondary

A method for the treatment of children with primary arterial hypertension / 2241470

The invention relates to medicine, namely Pediatrics

A method for the treatment of children with primary arterial hypertension / 2241469

The invention relates to medicine, namely to Pediatrics

Bathroom installation with spray liquid to the entire body and the way to create a bath environment with sprayed liquid / 2241431

The invention relates to medical technology, and in particular to methods and devices create an environment with the use of spray liquid for bathing

The method of treatment of ischemic heart disease / 2241430

The invention relates to medicine, in particular for rehabilitation, and can be used to treat ischemic heart disease

A method of treatment of an osteochondrosis of a backbone in a sanatorium or health care setting / 2241427

The invention relates to regenerative medicine and can be used for the treatment and prevention of osteochondrosis in the therapeutic and prophylactic institutions

A method of treatment of an osteochondrosis of a backbone in a sanatorium or health care setting / 2241427

The invention relates to regenerative medicine and can be used for the treatment and prevention of osteochondrosis in the therapeutic and prophylactic institutions

Method for the treatment of patients with neurocirculatory dystonia / 2240100

The invention relates to medicine, particularly cardiology and balneology

Method for the treatment of patients with neurocirculatory dystonia / 2240100

The invention relates to medicine, particularly cardiology and balneology

Mud tampon / 2245129

FIELD: medical engineering.

SUBSTANCE: device has monochrome radiation source designed as photodiode matrix of blue color tightly sealed in light impermeable partition of hollow casing of douche head. The douche head is screened with perforated cover. Cavity is formed between the cover and partition for supplying water. Each photodiode is mounted in front of holes in the cover. The perforated cover has wavy external surface. Autonomous low voltage power supply source is connected to radiation source via commutation device having switch and is enclosed in casing.

EFFECT: enhanced effectiveness of treatment; improved blood supply; reduced blood viscosity.

3 cl, 1 dwg

The invention relates to medical equipment, namely to physiotherapeutic devices that use the energy of light radiation.

A device for complex image enhancement weight [1], containing the sources of optical effects connected to the power supply control unit. Optical sources are fixed in space so as to provide irradiation spatially extended areas of the body, and as sources of radiation using a matrix of LEDs in the form of a semicylinder, superimposed on the couch. The device intensifies the metabolism in the skin and adjacent layers by enhancing blood flow, but the complexity of the design does not allow to apply it in everyday life.

It is also known a device for the irradiation of a “light shower” [6], considered as a prototype, which has a radiation source (laser) with svetovolokna connected to the center of the shower head. When you enable source radiation beams of light through the cavity of the head and a perforation in its bottom cover surface of the patient's body, with the inclusion of water leads to the distribution of light, due to the effect of total internal reflection, just inside the water jets. “Light shower” has combined physical impact on the entire surface of the body PAC is enta.

However, the device cannot be used at home due to the complexity of the control laser and the need for special training of personnel.

The technical result, which directed the present invention is to improve the efficacy of physical effects due to the combined effect of monochromatic light and Jacuzzi on the entire surface of the body, as well as to simplify the operation and use at home.

This is the device physiotherapeutic effects, contains a monochromatic source of radiation in the optical range, power supply, shower head, full body, which is overlapped with a perforated lid, while the radiation source is made in the form of a matrix of LEDs blue, tightly installed in the translucent wall of the housing of the shower head. Each of the LEDs is set opposite their respective coaxially spaced recesses in the wall and holes in the lid. Between the cover and the partition is formed a cavity for water supply. The cap has a wavy outer surface.

The power source is made low and Autonomous, connected to the radiation source through the switching device to switch and set the flax in the body.

The partition can be made of polymethylacrylate. In addition, the inner surface of the cover may have a coating that provides backward scattering light or a mirror.

In the works Acrage [2] capillaroscopy was established extremely effective stimulation of blood supply to internal organs due to the physical impact on the network of capillaries located in the immediate vicinity of the skin. In the works of the followers Acrage have been developed methods of activation at rest capillaries. For example, in the works Assalamou [3] it is known that the change of pressure water jets achieve increase capillary circulation through massage effect. As pointed Assalamou: “...in the active state some of capillaries capable of receiving seven hundred times more blood than at rest [3].

At the same time it is widely known physical effects of visible radiation. The change of pulse activity initiates segmental-reflex and local reactions activation of microcirculation irradiated organs, in addition, the radiation of the blue range of the spectrum stimulates photobiological processes, significantly reducing the viscosity of the blood [4]. Installed bactericidal and anti-inflammatory action of blue light with a wavelength of 440-450 nm

The combined impact on the patient's skin at the same time several physical parameters increases blood flow when exposed to light. Irradiation in combination with pressing the soft tissue when exposed to water jets accompanied by increasing its transmission [5].

The presence of the proposed device for physiotherapeutic treatment (“light soul”) irradiation with blue light and massage the whole body surface increases the efficiency impact, allows you to apply a therapeutic effect on various stages of complex therapy.

It also reduces overheating of the tissues of the body.

The drawing shows a General view of the device.

A device for physiotherapeutic effect consists of a shower head (see drawing), in the hollow body 1 which is placed offline low-voltage power source 2 (for example, they may be a group of batteries 12 In). The power source is connected through a switching device comprising a switch button 8 with a monochromatic light source of blue light matrix of LEDs 3.

LEDs are tightly installed in the partition 4 of translucent material, for example from polymethylacrylate. The partition wall 4 by a perforated cover 5 has a recess, the axial holes in the lid 5, between the wall and the roofs of the Oh formed cavity for supplying water 7, connected by a hose with a water supply (not shown).

Cover the shower head, overlapping the body cavity has a wavy outer surface, preferably made in the form of concentric rings.

The mirrored coating or coating backward scattering of light on the cover, as well as its waviness, provide intensive exposure, reducing losses.

The device operates as follows.

In the case of the shower head in the appropriate slot install the batteries of the power supply, deliver the water to the required temperature in the cavity for water supply and includes a button mounted on the housing of the shower head matrix of LEDs.

The light penetrating through the transparent wall of polymethylacrylate 4 and the layer of water covers the holes of the perforated cover, which form water jets 6. The beam of light from the led 3, placed opposite the hole, hits the end of the jet. Due to the effect of total internal reflection light does not go beyond the boundaries of the side surface of the stream and extends along it, as through the light.

At the point of contact of the water jet with the surface of the body conditions of total internal reflection are broken and the light propagating with almost no loss in the jet is absorbed by the skin surface and, consequently, the blood flowing in the network is the active capillaries of the subcutaneous layer, which are activated by the physical impact of the jets of water.

This is achieved by the combined physical impact on capillarie circulation, which significantly increases therapeutic effect.

The proposed device acts on capillary blood flow of the person by a combination of locally changing the temperature of the pulsating pressure and optical radiation.

The device is convenient to use, can be used in a domestic environment, it is compact and electrically safe (power supply voltage does not exceed 12 In).

Led emitters approximately 50-100 times less than laser emitters, and the service life of LEDs reaches 50000 hours.

Bibliography

[1] EN 2132985, 2000.

[2] A.Krogh “The Anatomy and discrimination of Capillaries London, 1936, Yall Univ. Press.

[3] Atamanov “secret wisdom of the human body (deep medicine”, Minsk, 1993, “Infared”.

[4] Vierastalo, Ebbehoj, Ustronics “Phototherapy”. M.: Medicine, 2001

[5] Huascaran “the increase in the passage of the laser and other radiation through a soft muddy the physical and biological environment. Quantum electronics, v.9, No. 7, 1982, s-1383.

[6] EN 6707 U1, 1998.

1. A device for physiotherapeutic effects, contains a monochromatic source of radiation in the optical range, the power supply and the shower is the head, hollow body which is overlapped perforated lid, characterized in that the radiation source is made in the form of a matrix of LEDs blue, tightly installed in the translucent wall of the housing of the shower head, each of the LEDs installed in front of the hole in the cover, between the cover and the partition is formed a cavity for water supply, perforated cover has a wavy outer surface, and the power source is made of low-voltage, self-contained, connected to the radiation source through the switching device with the switch and installed in the case.

2. The device according to claim 1, characterized in that the partition wall is made of polymethylacrylate.

3. The device according to claim 1, characterized in that the inner surface of the cover are coated backward scattering light or a mirror.